Tryptophan PET/CT scan study for different tumors
Part of Brain & nervous system, Cancer, Digestive system, Skin clinical trials.
This early-phase study tests a special PET/CT scan using labeled tryptophan to help doctors see how different tumors behave. The goal is to learn whether this scan can better identify and measure cancers in the brain or elsewhere.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your imaging must show a tumor/lesion that is at least 1 cm.
- You must be able to stay still in the PET/CT scanner for about 70 minutes.
- You must have recent scan images showing the tumor so doctors can compare results.
- You must have recent blood tests and a recent physical exam within the study time windows.
- If you can become pregnant, you must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests special PET/CT scans using a radioactive tracer to see cancer areas that have specific targets. It may help doctors better visualize tumors and plan next steps, using scans that you may already be familiar with (FDG) plus targeted tracers.
This study tests a new type of imaging scan (PET/CT or PET/MR) that uses a radioactive tracer to help doctors better detect and diagnose various cancers. The scan targets a specific protein found in tumors, which may help identify cancer more accurately than standard imaging.
This trial tests a new type of imaging scan that uses a special tracer to help doctors see solid tumors more clearly. The scan may help improve how tumors are detected and monitored during treatment.
This study uses a special PET/CT scan to take detailed pictures of gliomas (a type of brain tumor). It may help doctors understand your tumor better and plan your treatment.
This trial tests a special PET scan tracer (18F-FET) to see if it can help doctors better identify and plan treatment for brain tumors. It may be an option if you are scheduled for surgery for a suspected new glioma.
This study tests a special imaging agent called fluoroethyltyrosine (FET) to see if it can better detect brain tumors on PET scans. It may help doctors decide if a tumor has come back after treatment or better guide initial biopsy or surgery.
Hear when a new Metastatic Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.